Pre-Exposure Prophylaxis for HIV (PrEP) represents an innovative strategy in HIV prevention, designed for people who do not have the virus but are at risk of exposure. At the HPA Health Group, the PrEP consultation provides information, monitoring and support to patients in the correct use of this medication, strengthening both the safety and effectiveness of prevention.
PrEP involves taking a daily medication that significantly reduces the risk of HIV infection. It is recommended for those who have unprotected sexual intercourse with high-risk partners, for people with seropositive partners, or for individuals who are part of epidemiological contexts with increased exposure.
The use of PrEP within the HPA Health Group includes a comprehensive clinical assessment, regular laboratory screening and ongoing follow-up. This monitoring ensures not only the effectiveness of the treatment, but also the early detection of other sexually transmitted infections (STIs). In addition, the consultation reinforces safe sexual health practices, provides education on risks and offers personalised counselling.
The HPA Health Group reaffirms its commitment to sexual health and to the prevention of HIV and STIs, offering a confidential, safe and accessible service. With PrEP, it is possible to prevent HIV infection effectively, while maintaining the quality of life and autonomy in managing one’s health.
For more information, book your PrEP consultation.
1, December 2025